The inhaled antibiotics global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Inhaled Antibiotics Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The inhaled antibiotics market size has grown strongly in recent years. It will grow from <b>$1.46 billion in 2023 to $1.58 billion in 2024 at a compound annual growth rate (CAGR) of 7.8%. </b> The growth in the historic period can be attributed to regulatory support and approvals, shift from systemic to targeted delivery, rise in antibiotic resistance, increase in respiratory infections.
The inhaled antibiotics market size is expected to see strong growth in the next few years. It will grow to <b>$2.18 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. </b> The growth in the forecast period can be attributed to growing investments in research and development, expansion of clinical applications, increasing focus on personalized medicine, advancements in drug formulations, continued antibiotic resistance concerns. Major trends in the forecast period include continued innovation in formulations, patient-centric approach, increased research in respiratory health, shift towards targeted therapies, advancements in drug delivery systems.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/inhaled-antibiotics-global-market-report
Scope Of Inhaled Antibiotics Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Inhaled Antibiotics Market Overview
Market Drivers –
The increasing incidence of respiratory diseases is expected to propel the growth of the inhaled antibiotics market going forward. Respiratory disease is a disease that damages the lungs and airways and impairs breathing in people. Inhaled antibiotics enhance lung function, prevent lung function decline, extend the period between exacerbations, and enhance the quality of life in cystic fibrosis patients. For instance, in June 2023, according to reports published by the Australian Institute of Health and Welfare, an Australia-based national agency, there was a rise in respiratory disease-related deaths in 2021 i.e., 46,551 in Australia. Furthermore, in September 2022, according to the data published by The Lancet, a UK-based book and periodic data publishing organization, 11,255 new cases of respiratory syncytial virus (RSV) were recorded in the 2021 summer, which is 9.50% more. Therefore, an increasing incidence of respiratory diseases drives the inhaled antibiotics market .
Market Trends –
Investments in the development of inhaled antibiotics are a key trend gaining popularity in inhaled antibiotics market. Major pharmaceutical companies are investing in the development of inhaled antibiotics to sustain their position in the market. For instance, in December 2021, Enbiotix, a US-based drug development company invested $11 million in the development of antibiotics for lung infections. This funding would help with clinical testing of murepavadin, and ColiFin (inhaled colistimethate sodium) that are used for patients suffering from cystic fibrosis (CF).
The inhaled antibiotics market covered in this report is segmented –
1) By Product Type: Aerosol or Metered Dose Inhaler, Dry Powder Formulation, Spray, Other Types
2) By Application: Pneumonia, Asthma, Bronchitis, Other Applications
3) By End-User: Hospitals, Other End Users
Get an inside scoop of the inhaled antibiotics market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8738&type=smp
Regional Insights –
North America was the largest region in the inhaled antibiotics market share in 2023. The regions covered in the inhaled antibiotics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the inhaled antibiotics market report are Gilead Sciences Inc., Lupin Limited, Insmed Inc., Savara Inc., Joincare Pharmaceutical Group Industry Co. Ltd., Pharmaxis Ltd., Teva Pharmaceutical Industries Ltd., Raptor Pharmaceutical Corporation, Altan Pharma Limited, Cipla Limited, Maya Biotech Pvt. Ltd., Medisol Lifescience Pvt. Ltd., Nivon Specialties, Sentiss Pharma Pvt. Ltd., Ultratech India Limited, Midas Care Pharmaceuticals Pvt. Ltd., Precept Pharma Ltd., Luckys Pharma, Novartis AG, Bayer AG, Pfizer Inc., Grifols SA, Vertex Pharmaceuticals Inc., Aridis Pharmaceuticals, Bayer HealthCare, Nektar Therapeutics, Parion Sciences Inc., Zambon Group, Transave Inc., Alitair Pharmaceuticals, Synspira Therapeutics Inc., AIT Therapeutics Inc., Polyphor AG, Oppilan Pharma Ltd., OptiNose Inc.
Table of Contents
1. Executive Summary
2. Inhaled Antibiotics Market Report Structure
3. Inhaled Antibiotics Market Trends And Strategies
4. Inhaled Antibiotics Market – Macro Economic Scenario
5. Global Inhaled Antibiotics Market Size and Growth
.
.
.
31. Global Inhaled Antibiotics Market Competitive Benchmarking
32. Global Inhaled Antibiotics Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Inhaled Antibiotics Market
34. Inhaled Antibiotics Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Market Size - The retail digital transformation market size has grown exponentially in recent years. It…
Market Size - The quantum computing and technologies market size has grown exponentially in recent…
Market Size - The pan-tilt-zoom (PTZ) camera market size has grown rapidly in recent years. It…
The anti-spam software global market report 2024 from The Business Research Company provides comprehensive market…
The exercise and weight loss apps global market report 2024from The Business Research Company provides…
Market Size - The medical isotopes market size has grown strongly in recent years. It will…